Business tycoon offloads dieting brand SlimFast, aiming for a leaner portfolio
Revised Article:
SlimFast's Owner Sets Sale in Motion – What's Next for the Weight Loss Brand?
Hold onto your shakers, everyone! It's about to get shaken up in the weight loss world! The bosses at SlimFast, that trusty companion for many a diet directed journey, have enlisted some serious help to offload the brand. Word on the street is that they've teamed up with the banking crew over at Houlihan Lokey, ready to orchestrate an auction.
Now, here's the scoop: this sale marks more than four decades since SlimFast first graced our shelves back in the '70s. Glanbia – that's the Irish-based company we're talking about – got their hands on the brand in 2018, dropping a cool $350m on it.
According to our sources, Glanbia has been}_{\r\n}[1][4] eyeing a change for a while now; Mark Garvey, the chief financial officer, spilled the beans in February when he announced that Glanbia was planning to ditch SlimFast. He highlighted a significant shift in weight management consumer behavior as the driving force behind the decision.
But, with the rise of weight-loss drugs like Wegovy and Ozempic shaking up the dieting landscape, what does this shake-up mean for SlimFast? Well, let's just say that any potential buyer better have a keen understanding of this evolving market.
Sources close to the situation have hinted that Glanbia's advisors are marketing SlimFast based on a pipeline of exciting new product developments and strategic brand positioning. The deal, they say, could be sewn up later this year – that is, if the price is right.
Of course, Glanbia isn't saying a peep about this shake-up. But, with the industry changing faster than you can say "chocolate shake,"!Stay tuned for updates!
Money Matters Alerts
- Tesla's valuation plunged by a staggering $150bn following an ugly spat between Elon Musk and Donald Trump.
- Subscribe to our Money newsletter for your daily dose of finance.
- Diet Pills or Shakes?: The latest craze in weight loss is all about injections! But, before you jab, find out what you need to know about Wegovy and Ozempic.
Keep an eye out for more news about the SlimFast auctions and the weight loss industry at large. Stay hungry, my friends!
[1] [4]: Enrichment Data: Glanbia is working with Houlihan Lokey on a process to exit its weight management portfolio, dubbed "Project Lego". A sale would mark more than 45 years since SlimFast was founded. Despite the ongoing auction, specific details about potential buyers aren't publicly available. The sale is expected to be finalized later this year, depending on the price offered by prospective buyers. Potential buyers could include health and wellness companies, pharmaceutical companies, or private equity firms.
- The evolving weight management market could attract a variety of potential buyers for SlimFast, including health and wellness companies, pharmaceutical firms, and private equity groups.
- As the weight loss landscape shifts due to the rise of weight-loss drugs like Wegovy and Ozempic, any new owners of SlimFast must have a comprehensive understanding of these medical-conditions and the broader health-and-wellness industry.
- With the rising popularity of weight-loss alternatives like Wegovy and Ozempic, SlimFast's new owners may need to incorporate cutting-edge science and technology in their product developments and business strategies.
